Skip to main content

Table 2 Laboratory findings between non-rebleeding and rebleeding groups

From: Nomogram for predicting rebleeding after initial endoscopic epinephrine injection monotherapy hemostasis in patients with peptic ulcer bleeding: a retrospective cohort study

Variables

All subjects

(N = 360)

Non-rebleeding

(N = 309)

Rebleeding

(N = 51)

p value

HB on admission (g/L), median(IQR)

87 (72–110.8)

87 (73–114)

76 (62–97)

0.004

HB < 100 g/L (n [%])

234 [65.0]

195 [63.1]

39 [76.5]

0.064

WBC (× 109/L), median(IQR)

8.9 (6.5–11.8)

8.8 (6.4–11.7)

9.2 (7.5–14.3)

0.129

PLT (× 109/L), median (IQR)

191 (147.3–239.8)

191 (149.5–239.5)

189 (127–255)

0.664

BUN (mmol/L), median(IQR)

9.5 (6.5–13.0)

9.4 (6.4–12.6)

10.1 (6.9–13.8)

0.151

Cr (μmol/L), median (IQR)

73.5 (60.9–86.5)

73.3 (60.8–86.5)

74.4 (61.3–87.2)

0.766

ALB (g/L), median (IQR)

35.9 (30.9–40.2)

36.4 (31.6–40.8)

32.3 (27.1–36.7)

 < 0.001

ALB < 30 g/L (n [%])

74 (20.6)

51 (16.5)

23 (45.1)

 < 0.001

PT(s), median (IQR)

11.7 (11.1–12.6)

11.7 (11.1–12.5)

12.3 (11.6–14.9)

0.001

PT > 13 s (n [%])

68 (18.9)

45 (14.6)

23 (45.1)

 < 0.001

APTT(s), median (IQR)

24.3 (22.2–28.3)

24.1 (22.2–27.7)

26.8 (23.4–33.2)

0.005

INR, median (IQR)

1.03 (0.98–1.11)

1.03 (0.98–1.1)

1.07 (1–1.25)

0.009

  1. HB, Hemoglobin; WBC, White Blood Cell Count; PLT, Platelet; BUN, Blood Urea Nitrogen; Cr, Creatinine; ALB, Albumin; PT, Prothrombin Time; APTT, Activated Partial Thromboplastin Time; IQR, interquatile range; INR, International Normalized Ratio